Interestingly, the AHI-1-BCR-ABL-JAK2 complex was reported to play a key role in regulating IM response/resistance in BCR-ABL-transduced cells and primary CML stem/progenitors. This evidence concerns the gene JAK2 and chronic myelogenous leukemia, BCR-ABL1 positive.